Synergistic Photocatalytic and Photothermal Antibacterial Activity of (In, Nb) and (Al, Nb) Co‐Doped TiO2 Ceramics

Author:

Yang Minggang1,Zhang Yuan1,Alexander Revathi1,Liu Jinqiu2,Wu Wenwen2,Wang Guocheng1ORCID

Affiliation:

1. Research Center for Human Tissues and Organs Degeneration Shenzhen Institute of Advanced Technology Chinese Academy of Science Shenzhen Guangdong 518055 China

2. School of Physics and Information Technology Shaanxi Normal University Xian Shaanxi 710119 China

Abstract

Photodynamic and photothermal therapies are promising approaches to deal with implant‐associated infection. However, the efficacy of monotherapy is often insufficient, posing the importance of combinatory therapies. Herein, the AlNbTiO2 and InNbTiO2 ceramics are prepared by (In, Nb) and (Al, Nb) co‐doping into TiO2 ceramics via a solid‐phase reaction. The co‐doping enhances the visible/ near infrared (NIR) light adsorption and endows the TiO2 with excellent photocatalytic and photothermal properties, which is likely due to the formation of large defect‐dipole clusters and oxygen vacancies. The antibacterial efficacy of AlNbTiO2/InNbTiO2 ceramics is 99.04%/98.56% against E. coli and 95.06%/93.68% against S. aureus within 10 min under 808 nm NIR light irradiation, which is ascribed to the synergistic action of enhanced photocatalytic and photothermal effects. Cell culture experiments using MC3T3‐E1 cells prove that the viability and proliferation of MC3T3‐E1 cultured on TiO2 and AlNbTiO2/InNbTiO2 ceramics are comparable, emphasizing their excellent biocompatibility as well. This study suggests that AlNbTiO2/InNbTiO2 has potential application as an antibacterial bioceramic or coating for orthopedic implants.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3